| Name | SB 202190 |
|---|---|
| Supplier | BioGems |
| Catalog | 1523072 |
| Prices | $30.00, $55.00 |
| Sizes | 10 mg, 25 mg |
| Function Type | Inhibitor |
| Cas Number | 152121-30-7 |
| Chemical Name | 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one |
| Formula | C20H14FN3O |
| Molecular Weight | 331.3 |
| Purity | ≥98% |
| Description | SB 202190 is a selective and potent p38 MAP kinases inhibitor, binding to its ATP pocket. It has negligible inhibiting properties on other MAP kinases such as ERKs and JNKs. SB 202190 is reported to be used to induce cardiomyocyte differentiation from human embryonic stem cells and increase neural stem cell self-renewal. |
| Supplier Page | Shop |